The Prognostic Value of Body Fat Components in Metastasis Renal Cell Carcinoma Patients Treated with TKIs

PURPOSE: To assess the association between body fat components and survival status and tumor response for metastatic renal cell carcinoma (mRCC) patients treated with tyrosine kinase inhibitors (TKIs). PATIENTS AND METHODS: Patients with pathologically diagnosed and radiologically indicated mRCC wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jindong, Zhang, Xingming, Liu, Zhenhua, Song, Tingni, Zhu, Xudong, Zhang, Haoran, Wu, Mingpeng, Li, Xiang, Zeng, Hao, Shen, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012252/
https://www.ncbi.nlm.nih.gov/pubmed/32104071
http://dx.doi.org/10.2147/CMAR.S230973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012252/
https://www.ncbi.nlm.nih.gov/pubmed/32104071
http://dx.doi.org/10.2147/CMAR.S230973

Ejemplares similares